Stay updated on Lebrikizumab Long-term Safety Efficacy AD Clinical Trial
Sign up to get notified when there's something new on the Lebrikizumab Long-term Safety Efficacy AD Clinical Trial page.

Latest updates to the Lebrikizumab Long-term Safety Efficacy AD Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe webpage has updated its version from v2.15.0 to v2.15.2 and has removed older dates from February 2025, replacing them with new dates in April 2025.SummaryDifference0.3%
- Check18 days agoChange DetectedThe webpage has undergone significant changes, including the removal of detailed descriptions of a long-term study assessing the safety and efficacy of lebrikizumab for moderate-to-severe atopic dermatitis, and the addition of new identifiers and collaborators related to the study.SummaryDifference18%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 27, 2025, while a date for March 25, 2025, has been removed.SummaryDifference0.2%
- Check40 days agoChange DetectedThe page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3, replacing the previous date of February 27, 2025, and version 2.14.2.SummaryDifference0.1%
- Check69 days agoChange DetectedThe web page has updated its version from v2.14.1 to v2.14.2 and removed older dates from January 2025, replacing them with new dates in February 2025.SummaryDifference0.3%
- Check105 days agoChange DetectedThe website has been updated with new entries for January 2025, including a revision to v2.14.1, while previous updates from December 2024 have been removed.SummaryDifference0.5%
Stay in the know with updates to Lebrikizumab Long-term Safety Efficacy AD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lebrikizumab Long-term Safety Efficacy AD Clinical Trial page.